|
Apr 25
|
All You Need to Know About Takeda Pharmaceutical Co. (TAK) Rating Upgrade to Strong Buy
|
|
Apr 25
|
TAK or CTLT: Which Is the Better Value Stock Right Now?
|
|
Apr 25
|
20 Fastest Growing Health Tech Companies in the World
|
|
Apr 25
|
New Strong Buy Stocks for April 25th
|
|
Apr 25
|
Best Value Stocks to Buy for April 25th
|
|
Apr 25
|
Best Income Stocks to Buy for April 25th
|
|
Apr 23
|
Takeda Pharmaceutical: A Long-Term Cash Cow
|
|
Apr 23
|
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
|
|
Apr 22
|
Pharmas form joint venture to jumpstart Japanese drug research
|
|
Apr 22
|
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
|
|
Apr 19
|
MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
|
|
Apr 18
|
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
|
|
Apr 8
|
Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food
|
|
Apr 5
|
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
|
|
Mar 27
|
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
|
|
Mar 26
|
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
|
|
Mar 26
|
Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
|
|
Mar 25
|
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
|
|
Mar 19
|
Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
|
|
Mar 19
|
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
|